Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Discontinued Operations (Tables)

v3.8.0.1
Note 3 - Discontinued Operations (Tables)
3 Months Ended
Mar. 31, 2018
Notes Tables  
Disposal Groups, Including Discontinued Operations [Table Text Block]
   
March 31,
2018
   
December 31,
2017
 
Accrued liabilities
  $
    $
7,092
 
Liabilities associated with discontinued operations, current
  $
    $
7,092
 
   
Three Months Ended March 31,
 
   
2018
   
2017
 
Lymphoseek sales revenue
  $
    $
2,917,213
 
Cost of goods sold
   
     
364,192
 
Gross profit
   
     
2,553,021
 
Operating expenses:
               
Research and development
   
     
283,533
 
Selling, general and administrative
   
     
820,203
 
Total operating expenses
   
     
1,103,736
 
Income from discontinued operations
   
     
1,449,285
 
Interest expense
   
     
(1,718,506
)
Loss before income taxes
   
     
(269,221
)
Benefit from income taxes
   
     
13,360
 
Loss from discontinued operations
  $
    $
(255,861
)